HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Split liver transplant recipients do not have an increased frequency of acute kidney injury.

Abstract
Small series have suggested that split liver transplantation (SLT) has an increased frequency of peri-operative acute kidney injury (AKI). However, the optimal donor selection in this setting could have a favourable impact on renal outcomes. This was a retrospective single-centre study of 76 adults who underwent SLT (right extended lobe) and 301 adults who underwent elective full-size donation after brain death liver transplantation (FSLT). SLT recipients were less likely than unmatched FSLT recipients to develop AKI (≥stage 1 KDIGO criteria) (40.3% vs. 56.1%, P = 0.016) and had a reduced frequency of renal replacement therapy (11.8% vs. 21.9%, P = 0.049). In 72 pairs of SLT patients and propensity risk score-matched FSLT controls the incidence of AKI was not significantly different (40.3% vs. 47.2%, P = 0.473). However, SLT patients were less likely to require renal replacement therapy (11.1% vs. 23.6%, P = 0.078; adjusted OR 0.32; 95% CI 0.11-0.87, P = 0.026). There was no association between SLT and the development of chronic kidney disease (eGFR<60 ml/min/1.73 m(2) , log rank P = 0.534). In conclusion, SLT is not associated with an increased frequency of AKI. These observations support the postulation that the optimal donor status of SLT may result in less graft injury with renal sparing effects.
AuthorsJoanna A Leithead, Matthew J Armstrong, Christopher Corbett, Mark Andrew, Chirag Kothari, Bridget K Gunson, Darius Mirza, Paolo Muiesan, James W Ferguson
JournalTransplant international : official journal of the European Society for Organ Transplantation (Transpl Int) Vol. 27 Issue 11 Pg. 1125-34 (Nov 2014) ISSN: 1432-2277 [Electronic] Switzerland
PMID24964222 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Comment)
Copyright© 2014 Steunstichting ESOT.
Topics
  • General Surgery (education)
  • Humans
  • Liver Transplantation (education)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: